By www.reliablemarketsize.com
Global Overactive Bladder Drug Market Research Report 2023 Story
98
$ 2900
Overactive Bladder Drug Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Astellas Pharma, Inc. (Japan) Pfizer, Inc. (US) Teva Pharmaceutical Industries Limited (Israel) Allergan, Plc (Ireland) Medtronic plc (Ireland) Mylan N.V. (US) Endo International plc (Ireland) Hisamitsu Pharmaceutical Co., Inc. (Japan) Sanofi (France) Apotex, Inc. (Canada) Cogentix Medical, Inc. (US) Aurobindo Pharma Limited (India)